JP2013503842A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013503842A5 JP2013503842A5 JP2012527386A JP2012527386A JP2013503842A5 JP 2013503842 A5 JP2013503842 A5 JP 2013503842A5 JP 2012527386 A JP2012527386 A JP 2012527386A JP 2012527386 A JP2012527386 A JP 2012527386A JP 2013503842 A5 JP2013503842 A5 JP 2013503842A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- agent
- clec14a
- angiogenesis
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US23958409P | 2009-09-03 | 2009-09-03 | |
| US61/239,584 | 2009-09-03 | ||
| PCT/GB2010/001689 WO2011027132A1 (en) | 2009-09-03 | 2010-09-03 | Clec14a inhibitors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013503842A JP2013503842A (ja) | 2013-02-04 |
| JP2013503842A5 true JP2013503842A5 (https=) | 2013-10-17 |
| JP5962996B2 JP5962996B2 (ja) | 2016-08-03 |
Family
ID=43333027
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012527386A Expired - Fee Related JP5962996B2 (ja) | 2009-09-03 | 2010-09-03 | Ｃｌｅｃ１４ａ阻害剤 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US9255148B2 (https=) |
| EP (1) | EP2473529B1 (https=) |
| JP (1) | JP5962996B2 (https=) |
| AU (1) | AU2010290989B2 (https=) |
| CA (1) | CA2810119C (https=) |
| ES (1) | ES2567030T3 (https=) |
| HU (1) | HUE028878T2 (https=) |
| WO (1) | WO2011027132A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013187556A1 (en) * | 2012-06-14 | 2013-12-19 | Scripps Korea Antibody Institute | Novel antibody specific for clec14a and uses thereof |
| GB201501004D0 (en) * | 2015-01-21 | 2015-03-04 | Cancer Rec Tech Ltd | Inhibitors |
| EP3430050A1 (en) * | 2016-03-15 | 2019-01-23 | Cancer Research Technology Limited | Antibodies and related molecules and uses thereof |
| CA3015293A1 (en) * | 2016-03-15 | 2017-09-21 | Cancer Research Technology Limited | Chimeric antigen receptor |
| CN110312735A (zh) * | 2016-09-08 | 2019-10-08 | 宇里技术有限公司 | 特异性地结合至clec14a的去糖基化抗体及其用途 |
| CN113336830B (zh) * | 2017-03-17 | 2023-07-07 | 浙江孚诺医药股份有限公司 | 肿瘤靶向多肽、制备方法及其应用 |
| GB202219154D0 (en) | 2022-12-19 | 2023-02-01 | Metacurum Biotech Ab | Antibodies and uses thereof |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4348376A (en) | 1980-03-03 | 1982-09-07 | Goldenberg Milton David | Tumor localization and therapy with labeled anti-CEA antibody |
| US4946778A (en) | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
| US4987071A (en) | 1986-12-03 | 1991-01-22 | University Patents, Inc. | RNA ribozyme polymerases, dephosphorylases, restriction endoribonucleases and methods |
| US6765087B1 (en) | 1992-08-21 | 2004-07-20 | Vrije Universiteit Brussel | Immunoglobulins devoid of light chains |
| US6005079A (en) | 1992-08-21 | 1999-12-21 | Vrije Universiteit Brussels | Immunoglobulins devoid of light chains |
| AU701578B2 (en) | 1992-08-21 | 1999-02-04 | Vrije Universiteit Brussel | Immunoglobulins devoid of light chains |
| GB9223084D0 (en) | 1992-11-04 | 1992-12-16 | Imp Cancer Res Tech | Compounds to target cells |
| AU3374795A (en) | 1994-08-29 | 1996-03-22 | Prizm Pharmaceuticals, Inc. | Conjugates of vascular endothelial growth factor with targeted agents |
| EP0739981A1 (en) | 1995-04-25 | 1996-10-30 | Vrije Universiteit Brussel | Variable fragments of immunoglobulins - use for therapeutic or veterinary purposes |
| US5716081A (en) | 1996-03-11 | 1998-02-10 | Automotive Products (Usa), Inc. | Spring clip for quick connect coupling |
| US5846220A (en) | 1996-04-30 | 1998-12-08 | Medtronic, Inc. | Therapeutic method for treatment of Alzheimer's disease |
| ES2294799T3 (es) | 1996-06-27 | 2008-04-01 | Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw. | Moleculas de anticuerpos que interactuan especificamente con el sitio activo o hendidura de una molecula diana. |
| WO2002000690A2 (en) | 2000-06-23 | 2002-01-03 | Genentech, Inc. | Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis |
| GB9701425D0 (en) | 1997-01-24 | 1997-03-12 | Bioinvent Int Ab | A method for in vitro molecular evolution of protein function |
| US20020137890A1 (en) | 1997-03-31 | 2002-09-26 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| US20030054400A1 (en) | 1997-09-17 | 2003-03-20 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| US6225118B1 (en) | 1997-10-01 | 2001-05-01 | Biocure Limited | Multicellular in vitro assay of angiogenesis |
| US6894148B2 (en) | 1997-11-12 | 2005-05-17 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| US20020015950A1 (en) | 1999-07-07 | 2002-02-07 | Karen Anne Jones | Atherosclerosis-associated genes |
| ATE363489T1 (de) | 1999-03-08 | 2007-06-15 | Genentech Inc | In tumoren vervielfältigte gensequenzen und deren diagnostische verwendungen |
| KR100510795B1 (en) | 1999-08-31 | 2005-08-30 | Compositions and Methods for the Treatment of Tumor | |
| US7695959B2 (en) | 2000-05-23 | 2010-04-13 | Neurologix, Inc. | Glutamic acid decarboxylase (GAD) based delivery systems |
| US7498034B2 (en) | 2000-11-06 | 2009-03-03 | Cancer Research Technology Limited | Imaging, diagnosis and treatment of disease |
| WO2002079492A2 (en) | 2001-02-14 | 2002-10-10 | Protein Design Labs, Inc. | Methods of diagnosis of angiogenesis, compositions and methods of screening for angiogenesis modulators |
| US20040033495A1 (en) * | 2001-08-03 | 2004-02-19 | Eos Biotechnology, Inc. | Methods of diagnosis of angiogenesis, compositions and methods of screening for angiogenesis modulators |
| AU2003240495A1 (en) | 2002-06-04 | 2003-12-19 | Incyte Corporation | Diagnostics markers for lung cancer |
| US20060099143A1 (en) | 2002-11-20 | 2006-05-11 | Roy Bicknell | Antibodies binding to human magic roundabout (mr), polypeptides and uses thereof for inhibition angiogenesis |
| US8293710B2 (en) | 2005-01-03 | 2012-10-23 | Blue Blood Biotech Corp. | Method for treating wounds using an EGF-like domain of thrombomodulin |
| US20060148695A1 (en) | 2005-01-03 | 2006-07-06 | National Cheng Kung University | Novel angiogenic composition and use thereof |
| AU2006223579A1 (en) * | 2005-03-11 | 2006-09-21 | Genentech, Inc. | Gene disruptions, compositions and methods relating thereto |
| JP4832515B2 (ja) * | 2005-06-09 | 2011-12-07 | ブルー ブラッド バイオテック コーポレーション | 創傷治癒用の組成物及びその使用 |
-
2010
- 2010-09-03 HU HUE10757617A patent/HUE028878T2/en unknown
- 2010-09-03 EP EP10757617.5A patent/EP2473529B1/en active Active
- 2010-09-03 US US13/393,921 patent/US9255148B2/en active Active
- 2010-09-03 CA CA2810119A patent/CA2810119C/en not_active Expired - Fee Related
- 2010-09-03 JP JP2012527386A patent/JP5962996B2/ja not_active Expired - Fee Related
- 2010-09-03 AU AU2010290989A patent/AU2010290989B2/en not_active Ceased
- 2010-09-03 WO PCT/GB2010/001689 patent/WO2011027132A1/en not_active Ceased
- 2010-09-03 ES ES10757617.5T patent/ES2567030T3/es active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7337133B2 (ja) | ＴＡＭおよびＭＥＴキナーゼの阻害薬としてのピラゾロ［３，４－ｂ］ピリジン化合物 | |
| ES2290199T3 (es) | Mezcla que incluye un agente que reduce la actividad de fcve y un agente que reduce la actividad de fce. | |
| CN106995493B (zh) | 氯毒素多肽和结合物及其应用 | |
| TWI910725B (zh) | 抗體-藥物結合物之用途 | |
| JP2013503842A5 (https=) | ||
| ES2656168T3 (es) | Anticuerpo anti cadherina marcado con un metal radioactivo | |
| TW202019487A (zh) | 抗體-藥物結合物及微管蛋白抑制劑之組合 | |
| ES2933266T3 (es) | Administración de múltiples bolos de [6R] MTHF en una quimioterapia basada en 5-fluorouracilo | |
| JP2015500287A (ja) | 抗体−薬物のコンジュゲート、ならびに関連する化合物、組成物および方法 | |
| JP2008507536A5 (https=) | ||
| KR101993963B1 (ko) | 항 종양제 및 항 종양 효과 증강제 | |
| JP2021527051A (ja) | ピラゾロ−ピリミジン−アミノ−シクロアルキル化合物及びその治療的使用 | |
| KR20190039153A (ko) | 악성 종양 표적 펩티드 | |
| CN110709106A (zh) | 放射性标记的生物分子及其应用 | |
| EP3125901B1 (en) | Derivatives of cephalosporin for treating cancer | |
| US20230116137A1 (en) | Methods for treating colorectal and metastatic colorectal cancers | |
| AU2004292933B2 (en) | Targeting of Erb antigens | |
| KR20230149767A (ko) | Ddx5 단백질에 결합하는 캄토테신 유도체 및 이의 프로드럭 | |
| US11795197B2 (en) | Peptide compositions for immuno-oncology molecular imaging and targeted drug delivery | |
| CN1921891B (zh) | 连接到杯芳烃上的生长因子结合化合物 | |
| Tseng et al. | Engineering a modular FAP-targeting ferritin-based drug nanocarrier for enhanced glioblastoma theranostics | |
| Gyllenbäck et al. | IL1RAP-targeting antibody-drug conjugate: a novel therapeutic targeting both tumor cells and the tumor microenvironment | |
| CN119584994A (zh) | 预靶向 | |
| BR122024023393A2 (pt) | Uso de um conjugado de anticorpo-fármaco, composição farmacêutica, e, combinação farmacêutica | |
| BR122024023391A2 (pt) | Uso de um conjugado de anticorpo-fármaco, composição farmacêutica, e, combinação farmacêutica |